Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The combination of mitoxantrone and clofarabine as reinduction therapy will be safe, well
tolerated and effective in children, adolescents and young adults with poor risk
refractory/relapsed acute leukemia and high grade non-Hodgkin lymphoma (NHL).